StonvexLoading…
StonvexStonvexStonvexCore line items from BMRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $152.43M | $141.27M | $139.49M | $130.04M |
Operating Income | $-52.48M | $-13.84M | $26.04M | $63.51M |
Net Income | $-35.67M | $-8.41M | $19.89M | $46.59M |
EPS (Diluted) | $-2.24 | $-0.52 | $1.24 | $2.92 |
Total Assets | $3.90B | $3.70B | $3.80B | $4.15B |
Total Liabilities | $3.51B | $3.27B | $3.36B | $3.74B |
Cash & Equivalents | $225.30M | $137.30M | $30.45M | $45.42M |
Free Cash Flow OCF − CapEx | $37.26M | $27.84M | $33.91M | $53.01M |
Shares Outstanding | 16.10M | 16.09M | 16.16M | 16.03M |